{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T19:18:18Z","timestamp":1788722298661,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,5]]},"abstract":"<jats:p>\n                    The safety of tranexamic acid (TXA) in patients with recent coronavirus disease (COVID-19) infection undergoing major arthroplasty remains unclear. We aimed to evaluate whether TXA increases thromboembolic risk in post-COVID-19 patients undergoing major arthroplasty. Using the TriNetX database, we identified patients aged \u226550 years who underwent total knee or hip arthroplasty with documented COVID-19 within 3 months prior to surgery. Patients who received TXA on the day of surgery were compared with those who did not. The primary outcome was 6-month risk of venous thromboembolism (VTE), with secondary outcomes including cerebral infarction, mortality, intensive care unit (ICU) admission, acute kidney injury (AKI), sepsis, and pneumonia. After matching (26,366 patients for each group), analysis revealed that TXA use was not associated with an increased risk of VTE (odds ratio [OR] 1.09, 95% confidence interval [CI] 0.90\u20131.32,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.404), cerebral infarction (OR 0.86, 95% CI 0.67\u20131.09,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.215), mortality (OR 0.81, 95% CI 0.60\u20131.10,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.174), or other complications at 6 months. Notably, TXA was associated with a significantly reduced risk of ICU admissions (OR 0.74, 95% CI 0.62\u20130.89,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001). Sensitivity analysis showed that TXA provided additional benefits in patients with prior COVID-19 hospitalization, including reduced mortality (OR 0.53,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.003), lower risk of AKI (OR 0.79,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.002), and decreased incidence of sepsis (OR 0.77,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.038). Sex-based analysis revealed more pronounced benefits in female patients, particularly for ICU admission and AKI. TXA use in post-COVID patients undergoing major arthroplasty was associated with better long-term outcomes without increasing thromboembolic risk, supporting the continued use of TXA in this patient population.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044317","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:04:30Z","timestamp":1757354670000},"page":"e44317","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Thromboembolic safety and clinical benefits of tranexamic acid beyond hemostasis in post-COVID-19 patients undergoing major arthroplasty: A STROBE-compliant retrospective study"],"prefix":"10.1097","volume":"104","author":[{"given":"Yu-Yu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Chi Mei Medical Center, Chiali, Tainan, Taiwan"},{"name":"Department of Leisure and Sports Management, CTBC University of Technology, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Sian","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ning","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yew","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-8085","authenticated-orcid":false,"given":"Kuo-Chuan","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251029","first-page":"187","article-title":"Utilization of tranexamic acid in surgical orthopaedic practice: indications and current considerations.","volume":"13","author":"Haratian","year":"2021","journal-title":"Orthop Res Rev"},{"key":"R2-20251029","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s12630-021-01967-7","article-title":"Tranexamic acid: current use in obstetrics, major orthopedic, and trauma surgery.","volume":"68","author":"Wong","year":"2021","journal-title":"Can J Anaesth"},{"key":"R3-20251029","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","article-title":"Tranexamic acid in patients undergoing noncardiac surgery.","volume":"386","author":"Devereaux","year":"2022","journal-title":"N Engl J Med"},{"key":"R4-20251029","doi-asserted-by":"crossref","first-page":"e22999","DOI":"10.1097\/MD.0000000000022999","article-title":"Comparison of oral versus intravenous tranexamic acid in total knee and hip arthroplasty: a GRADE analysis and meta-analysis.","volume":"99","author":"Sun","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R5-20251029","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/j.arth.2018.06.023","article-title":"The efficacy of tranexamic acid in total hip arthroplasty: a network meta-analysis.","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"},{"key":"R7-20251029","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jor.2024.08.004","article-title":"Impact of tranexamic acid use in total hip replacement patients: a systematic review and meta-analysis.","volume":"60","author":"Liu","year":"2025","journal-title":"J Orthop"},{"key":"R8-20251029","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1213\/ANE.0000000000006039","article-title":"Update on applications and limitations of perioperative tranexamic acid.","volume":"135","author":"Patel","year":"2022","journal-title":"Anesth Analg"},{"key":"R9-20251029","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00590-022-03387-9","article-title":"Update on the efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis.","volume":"33","author":"Miangul","year":"2023","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"R10-20251029","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/ALN.0000000000003772","article-title":"Safety of tranexamic acid in hip and knee arthroplasty in high-risk patients.","volume":"135","author":"Poeran","year":"2021","journal-title":"Anesthesiology"},{"key":"R11-20251029","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2106\/JBJS.15.01010","article-title":"The michigan experience with safety and effectiveness of tranexamic acid use in hip and knee arthroplasty.","volume":"98","author":"Hallstrom","year":"2016","journal-title":"J Bone Joint Surg Am"},{"key":"R12-20251029","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/anae.15563","article-title":"SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.","volume":"77","year":"2022","journal-title":"Anaesthesia"},{"key":"R13-20251029","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/17474086.2023.2288154","article-title":"Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection.","volume":"16","author":"Boccatonda","year":"2023","journal-title":"Expert Rev Hematol"},{"key":"R14-20251029","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/ajh.25982","article-title":"Thrombosis in COVID\u201019.","volume":"95","author":"Hanff","year":"2020","journal-title":"Am J Hematol"},{"key":"R15-20251029","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/SHK.0000000000001660","article-title":"COVID-19 associated hypercoagulability: manifestations, mechanisms, and management.","volume":"55","author":"Mazzeffi","year":"2021","journal-title":"Shock"},{"key":"R16-20251029","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.14849","article-title":"Thromboinflammation and the hypercoagulability of COVID\u201019.","volume":"18","author":"Connors","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R17-20251029","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/ajh.26575","article-title":"Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: assessing the long\u2010term outcomes in COVID\u201019 patients.","volume":"97","author":"Fan","year":"2022","journal-title":"Am J Hematol"},{"key":"R18-20251029","doi-asserted-by":"crossref","first-page":"1041236","DOI":"10.3389\/fmed.2022.1041236","article-title":"Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges.","volume":"9","author":"Oliveira","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R19-20251029","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10787-025-01679-0","article-title":"Anti-inflammatory effect of multi-dose tranexamic acid in hip and knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials.","volume":"33","author":"Rui","year":"2025","journal-title":"Inflammopharmacology"},{"key":"R20-20251029","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1111\/trf.16976","article-title":"Tranexamic acid: beyond antifibrinolysis.","volume":"62","author":"Prudovsky","year":"2022","journal-title":"Transfusion"},{"key":"R21-20251029","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00264-021-05182-3","article-title":"Tranexamic acid attenuates early post-operative systemic inflammatory response and nutritional loss and avoids reduction of fibrinogen in total hip arthroplasty within an enhanced recovery after surgery pathway.","volume":"45","author":"Changjun","year":"2021","journal-title":"Int Orthop"},{"key":"R22-20251029","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10456-023-09885-6","article-title":"Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation.","volume":"26","author":"Kuchler","year":"2023","journal-title":"Angiogenesis"},{"key":"R23-20251029","doi-asserted-by":"crossref","first-page":"887386","DOI":"10.3389\/fphar.2022.887386","article-title":"Does tranexamic acid reduce the blood loss in various surgeries? An umbrella review of state-of-the-art meta-analysis.","volume":"13","author":"Hong","year":"2022","journal-title":"Front Pharmacol"},{"key":"R24-20251029","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(18)31777-X","article-title":"Hip replacement.","volume":"392","author":"Ferguson","year":"2018","journal-title":"Lancet"},{"key":"R25-20251029","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/EJA.0000000000000202","article-title":"PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study.","volume":"32","author":"Lasocki","year":"2015","journal-title":"Eur J Anaesthesiol"},{"key":"R26-20251029","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.arth.2021.08.018","article-title":"Who is still receiving blood transfusions after primary and revision total joint arthroplasty?","volume":"37","author":"DeMik","year":"2022","journal-title":"J Arthroplasty"},{"key":"R27-20251029","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1089\/jwh.2023.0665","article-title":"Adjusting current hemoglobin thresholds: a way to improve outcome in women undergoing major surgery.","volume":"33","author":"Netz","year":"2024","journal-title":"J Womens Health (Larchmt)"},{"key":"R28-20251029","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19.","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"R29-20251029","doi-asserted-by":"crossref","first-page":"e210884","DOI":"10.1001\/jamasurg.2021.0884","article-title":"Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression.","volume":"156","author":"Taeuber","year":"2021","journal-title":"JAMA Surg"},{"key":"R30-20251029","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.3390\/jcm12124057","article-title":"Assessing humoral immuno-inflammatory pathways associated with respiratory failure in COVID-19 patients.","volume":"12","author":"Regolo","year":"2023","journal-title":"J Clin Med"},{"key":"R31-20251029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13037-020-00262-6","article-title":"Postoperative mortality among surgical patients with COVID-19: a systematic review and meta-analysis.","volume":"14","author":"Abate","year":"2020","journal-title":"Patient Saf Surg"},{"key":"R32-20251029","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","article-title":"Immune response in COVID-19: a review.","volume":"13","author":"Chowdhury","year":"2020","journal-title":"J Infect Public Health"},{"key":"R33-20251029","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","article-title":"Cardiovascular complications in COVID-19.","volume":"38","author":"Long","year":"2020","journal-title":"Am J Emerg Med"},{"key":"R34-20251029","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/trf.14995","article-title":"A rationale for universal tranexamic acid in major joint arthroplasty: overall efficacy and impact of risk factors for transfusion.","volume":"59","author":"Pavenski","year":"2019","journal-title":"Transfusion"},{"key":"R35-20251029","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jss.2022.06.017","article-title":"A propensity-matched analysis of tranexamic acid and acute respiratory distress syndrome in trauma patients.","volume":"280","author":"Taghavi","year":"2022","journal-title":"J Surg Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:02:58Z","timestamp":1761746578000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":34,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044317","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"2025-07-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}